Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
SR One
Biotech
Zenas bags $200M series C to reach a handful of key mAB readouts
Zenas' $200 million series C is the company's second consecutive nine-digit financing.
Max Bayer
May 7, 2024 7:00am
CRISPR Tx director: It’s ‘still early days’ on sealing new deals
Jan 10, 2024 10:57am
Gary Glick's Odyssey begins with $218M for 7 assets
Dec 7, 2021 7:00am
HotSpot collects $100M to bankroll trials of allosteric drugs
Nov 29, 2021 7:00am
SR One breaks off from GlaxoSmithKline, banks $500M fund
Nov 19, 2020 10:24am
Tranquis debuts with $30M for next-gen neurodegenerative drugs
Jul 9, 2020 7:00am
